Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7069973
Reference Type
Journal Article
Title
Neovascularization of synthetic membranes directed by membrane microarchitecture
Author(s)
Brauker, JH; Carr-Brendel, VE; Martinson, LA; Crudele, J; Johnston, WD; Johnson, RC; ,
Year
1995
Is Peer Reviewed?
1
Journal
Journal of Biomedical Materials Research
ISSN:
0021-9304
EISSN:
1097-4636
Publisher
JOHN WILEY & SONS INC
Location
NEW YORK
Page Numbers
1517-1524
Language
English
PMID
8600142
DOI
10.1002/jbm.820291208
Web of Science Id
WOS:A1995TG45900008
Abstract
Transplantation of tissues enclosed within a membrane device designed to protect the cells from immune rejection (immunoisolation) provides an opportunity to treat a variety of disease conditions. Successful implementation of immunoisolation has been hampered by the foreign-body reaction to biomaterials. We screened a variety of commercially available membranes for foreign-body reactions following implantation under the skin of rats. Histologic analysis revealed that neovascularization at the membrane-tissue interface occurred in several membranes that had pore sizes large enough to allow complete penetration by host cells (0.8-8 microns pore size). When the vascularization of the membrane-tissue interface of 5-microns-pore-size polytetrafluoroethylene (PTFE) membranes was compared to 0.02-microns-pore-size PTFE membranes, it was found that the larger pore membranes had 80-100-fold more vascular structures. The increased vascularization was observed even though the larger pore membrane was laminated to a smaller pore inner membrane to prevent cell entry into the prototype immunoisolation device. This significantly higher level of vascularization was maintained for 1 year in the subcutaneous site in rats.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity